PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary hypertension |
| Phenotype | C0024115|pulmonary disease |
| Sentences | 29 |
| PubMedID- 26336405 | Of the patients who were not qualified for the study, 10 had aortic stenosis, 4 suffered from alcoholism, 6 neoplastic disease, 11 chronic obturative pulmonary disease with pulmonary hypertension, 9 diabetes mellitus, and 10 active myocarditis according to the dallas classification. |
| PubMedID- 23549775 | This case study presents a 44-year old man with chronic obstructive pulmonary disease and "out of proportion" pulmonary hypertension. |
| PubMedID- 20819757 | The incidence and clinical course of pulmonary hypertension associated with chronic obstructive pulmonary disease is best known among the pulmonary hypertension associated with lung diseases. |
| PubMedID- 22333502 | Objective: the levels of c-reactive protein (crp), tumor necrosis factor (tnf)-alpha, brain natriuretic peptide (bnp) and endothelin-1 (et-1) were investigated to analyze the systemic inflammation in chronic obstructive pulmonary disease (copd) patients with and without pulmonary hypertension. |
| PubMedID- 20364612 | pulmonary hypertension associated with chronic obstructive pulmonary disease. |
| PubMedID- 21393985 | The objective of this study was to investigate the associations among clinical, impedance cardiography, echocardiography, and chest roentgenography data in diagnosis of pulmonary hypertension for patients with cardiovascular and pulmonary diseases. |
| PubMedID- 22461045 | Background: the speckle tracking echocardiography (ste) method shows the presence of right ventricular (rv) dysfunction before the advent of rv failure and pulmonary hypertension in patients with cardiopulmonary disease. |
| PubMedID- 26064454 | Acute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary disease. |
| PubMedID- 26492415 | Background: patients with severe pulmonary hypertension (ph) associated with chronic obstructive pulmonary disease (copd) present a poor outcome. |
| PubMedID- 25050435 | Aims: we aimed to assess the relationship between right ventricle (rv) dysfunction parameters and the soluble il-1 receptor family member (sst2) in patients with secondary pulmonary hypertension owing tochronic obstructive pulmonary disease. |
| PubMedID- 24228853 | Role of vasoactive intestinal peptide in chronic obstructive pulmonary disease with pulmonary hypertension. |
| PubMedID- 22839713 | [association of parameters of heart rate variability with severity of bronchial obstruction and presence of pulmonary hypertension in patients with chronic obstructive pulmonary disease]. |
| PubMedID- 22307907 | Many chronic pulmonary diseases are associated with pulmonary hypertension (ph) and pulmonary vascular remodeling, which is a term that continues to be used to describe a wide spectrum of vascular abnormalities. |
| PubMedID- 25774911 | pulmonary hypertension (ph) is associated with several cardiopulmonary diseases that are prevalent among elderly patients [1–4]. |
| PubMedID- 26277885 | Background: there is no recommendation for treating pulmonary hypertension (ph) when associated with chronic obstructive pulmonary disease (copd). |
| PubMedID- 26539466 | In group (2) chronic obstructive pulmonary disease with pulmonary hypertension (copd-ph) patients (n = 22), copd were diagnosed by pulmonologist and estimated mean pap ≥ 25 mmhg by echocardiography. |
| PubMedID- 26064044 | Aim: the aim of the current study is to evaluate acute vasoreactivity test (avt) results in severe pulmonary hypertension patients with chronic obstructive pulmonary disease and to compare the demographical, clinical, and laboratory variables in positive and negative cases. |
| PubMedID- 25176971 | The loss of pulmonary vessels has been shown to be related to the severity of pulmonary hypertension in patients with chronic obstructive pulmonary disease (copd). |
| PubMedID- 26453478 | Potential role of ct metrics in chronic obstructive pulmonary disease with pulmonary hypertension. |
| PubMedID- 24578830 | Background: since pulmonary hypertension (ph) in patients with chronic obstructive pulmonary diseases (copd) causes poor prognosis and inflammatory process involved in ph, it is supposed that statins with anti-inflammatory effects might be useful in the treatment of ph. |
| PubMedID- 25708588 | Cigarette smoking contributes to the development of pulmonary hypertension (ph) complicated with chronic obstructive pulmonary disease (copd), and the pulmonary vascular remodeling, the structural basis of ph, could be attributed to abnormal proliferation of pulmonary artery smooth muscle cells (pasmcs).in this study, morphometrical analysis showed that the pulmonary vessel wall thickness in smoker group and copd group was significantly greater than in nonsmokers. |
| PubMedID- 21575307 | Background: chronic obstructive pulmonary disease (copd) can lead to pulmonary hypertension and cor pulmonale, which are predictors of mortality. |
| PubMedID- 25225149 | Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease. |
| PubMedID- 25469102 | Objective: this study strived to evaluate the relationship between degree of pulmonary emphysema and cardiac ventricular function in chronic obstructive pulmonary disease (copd) patients with pulmonary hypertension (ph) using electrocardiographic-gated multidetector computed tomography (ct). |
| PubMedID- 23855769 | Adenosine a2b receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary disease. |
| PubMedID- 26304628 | Inhibition of hmg-coa reductase (3-hydroxy-3-methyl-glutaryl-coa) by statins is an established treatment for the prevention of cardiovascular disease, and has recently been found to improve exercise capacity in chronic obstructive pulmonary disease patients with pulmonary hypertension 25. the mechanisms might include a beneficial effect on nitric oxide 26,27 and inhibition of endothelin 25. here, we show that simvastatin can impair the increase in dietary-induced pulmonary fibrosis, an affect clearly not related to either a decrease in plasma cholesterol or homocysteine, indicative of the pleiotropic role of simvastatin therapy. |
| PubMedID- 25922708 | Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis. |
| PubMedID- 24015329 | [153] in a recent study, eight patients with pulmonary hypertension associated with chronic obstructive pulmonary disease were daily treated with 200 mg of dhea. |
| PubMedID- 22059898 | At admission, the boy already had complications—chronic pulmonary disease with pulmonary hypertension, and consequential myocardiopathy, hepatosplenomegaly, lymphadenopathy, autoimmune phenomena, malabsorption, growth retardation, and failure to thrive. |
Page: 1